— Know what they know.
Not Investment Advice
Also trades as: TMDIF (OTC) · $vol 0M · TMD.TO (TSX) · $vol 0M

TMDI NASDAQ

Titan Medical Inc.
1W: -31.7% 1M: -83.9% 3M: -76.8% 1Y: -72.5% 3Y: -45.1%
$0.14
Last traded 2023-03-09 — delisted
NASDAQ · Healthcare · Medical - Devices · $15.7M mcap · 112M float · 3.47% daily turnover

Balance Sheet Trends

Total Assets
$47M +58.3% ▲
5Y CAGR: +45.7%
Total Liabilities
$12M -72.7% ▼
5Y CAGR: +12.6%
Shareholders Equity
$35M +355.6% ▲
5Y CAGR: +126.3%
Cash & Investments
$32M +26.8% ▲
5Y CAGR: +49.4%
Total Debt
$1M -52.6% ▼
Net Debt
-$31M -36.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$26M$100K$814K$25M$32M
Short-Term Investments$0$11M$0$0$0
Cash & ST Investments$26M$11M$814K$25M$32M
Net Receivables$80K$143K$84K$72K$8M
Inventory$0$0$0$0$0
Other Current Assets$3M$9M$851K$1M$3M
Total Current Assets$29M$21M$2M$27M$44M
Property, Plant & Equip.$10K$0$30K$1M$2M
Goodwill & Intangibles$770K$1M$2M$2M$2M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0-$10$0$0$0
Total Non-Current Assets$780K$1M$2M$3M$4M
Total Assets$30M$22M$3M$30M$47M
— Liabilities —
Accounts Payable$0$0$0$0-$56K
Short-Term Debt$0$0$21K$2M$346K
Deferred Revenue$0$0$0$0$56K
Other Current Liabilities$20M$18M$15M$41M$11M
Total Current Liabilities$20M$18M$15M$43M$11M
Long-Term Debt$0$0$8K$0$981K
Other Non-Current Liab.$0$0$0$751K$1M
Total Non-Current Liabilities$0$0$8K$751K$1M
Total Liabilities$20M$18M$15M$44M$12M
— Equity —
Common Stock$154M$171M$195M$216M$263M
Retained Earnings-$150M-$173M-$215M-$239M-$254M
Accumulated OCI$0-$518K-$4K-$144K$0
Total Stockholders Equity$10M$4M-$12M-$14M$35M
Total Liabilities & Equity$30M$22M$3M$30M$47M
— Key Metrics —
Total Debt$0$0$29K$3M$1M
Net Debt-$26M-$100K-$785K-$23M-$31M
Total Investments$0$11M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms